Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (16 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

QuidelOrtho's (QDEL) Latest FDA Nod to Boost Diagnostic Testing

QuidelOrtho's (QDEL) receipt of the FDA's latest approval is likely to improve clinical care, provide cost savings and deliver sample-to-result molecular testing across all laboratory settings.

The Zacks Analyst Blog Highlights Otter Tail, Rollins, DaVita and NetEase

Otter Tail, Rollins, DaVita and NetEase are included in this Analyst Blog.

Veeva Systems (VEEV) Vault Quality Offerings Adopted by Recipharm

Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid Recipharm in boosting its operational efficiencies.

3 Reasons to Add HealthEquity (HQY) Stock to Your Portfolio

HealthEquity's (HQY) strength in HSA raises optimism about the stock.

Sanghamitra Saha headshot

Santa Claus Rally Sets In: 4 Stocks From Top Sectors to Play

Tap top-ranked Otter Tail (OTTR), Rollins (ROL), DaVita (DVA) and NetEase (NTES) -- that come from top-ranked sectors too -- should realize the ongoing Fed-induced Santa Claus rally in 2023.

Best Growth Stocks to Buy for December 20th

MPTI, LZ and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 20, 2023.

Masimo's (MASI) Stork Baby Monitoring System Approved by FDA

The latest FDA clearance of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.

Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now

QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.

Glaukos (GKOS) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

Ensign Group (ENSG) Sanctions 4% Quarterly Dividend Hike

Ensign Group (ENSG) announces a dividend hike, underlining a strong financial position and continued focus on deploying capital to shareholders.

The Zacks Analyst Blog Highlights Everest Group, Comcast, 3M, Molson Coors Beverage and DaVita

Everest Group, Comcast, 3M, Molson Coors Beverage and DaVita are included in this Analyst Blog.

Best Growth Stocks to Buy for December 18th

DVA, EAT and EG made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 18, 2023.

Here's Why You Should Retain Catalent (CTLT) Stock for Now

Catalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock.

Sweta Killa headshot

5 Undervalued S&P 500 Stocks to Buy for 2024

Investors seeking to tap the bullish momentum in the S&P 500 should invest in undervalued stocks like Everest Group (EG), Comcast (CMCSA), 3M Company (MMM), Molson Coors (TAP) and DaVita (DVA).

Nalak Das headshot

5 Top Growth Stocks to Make the Most of Santa Claus Rally

We have narrowed our search to five growth stocks that have solid upside left for the rest of 2023. These are: DOCU, DUOL, DVA, VRT, PLTR.

Boston Scientific (BSX) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment.

Integer Holdings (ITGR) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Integer Holdings' (ITGR) solid foothold in the broader MedTech space.

Masimo's (MASI) ORi Favored by Study for PaO2 Information

Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.

Here's Why You Should Retain Surmodics (SRDX) Stock for Now

Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Best Growth Stocks to Buy for December 12th

GFF, DVA and EG made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 12, 2023.

The Zacks Analyst Blog Highlights Everest Group, Comcast, 3M, Molson Coors Beverage and DaVita

Everest Group, Comcast, 3M, Molson Coors Beverage and DaVita are part of the Zacks top Analyst Blog.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Sweta Killa headshot

5 Undervalued Stocks in the S&P 500 ETF to Buy for 2024

Many stocks in the S&P 500 ETF may be undervalued and have the potential to rise toward their peak values.

Why You Should Retain Merit Medical (MMSI) Stock for Now

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.